thalidomide has been researched along with Pulmonary Edema in 2 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Pulmonary Edema: Excessive accumulation of extravascular fluid in the lung, an indication of a serious underlying disease or disorder. Pulmonary edema prevents efficient PULMONARY GAS EXCHANGE in the PULMONARY ALVEOLI, and can be life-threatening.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pyoderma gangrenosum is a rare neutrophilic dermatosis that affects 4% of children." | 1.37 | [Pyoderma gangrenosum and Behçet's disease: a study of two pediatric cases]. ( Benchikhi, H; Bouayad, K; Chiheb, S; Hali, F; Khadir, K; Mikou, N, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zheng, F | 1 |
| Zhu, J | 1 |
| Zhang, W | 1 |
| Fu, Y | 1 |
| Lin, Z | 1 |
| Hali, F | 1 |
| Khadir, K | 1 |
| Chiheb, S | 1 |
| Bouayad, K | 1 |
| Mikou, N | 1 |
| Benchikhi, H | 1 |
2 other studies available for thalidomide and Pulmonary Edema
| Article | Year |
|---|---|
Thal protects against paraquat-induced lung injury through a microRNA-141/HDAC6/IκBα-NF-κB axis in rat and cell models.
Topics: Animals; Apoptosis; Cell Line; Disease Models, Animal; Female; Histone Deacetylase 6; Inflammation M | 2021 |
[Pyoderma gangrenosum and Behçet's disease: a study of two pediatric cases].
Topics: Adolescent; Behcet Syndrome; Child; Dermatologic Agents; Drug Therapy, Combination; Fatal Outcome; F | 2011 |